Moderna continues to dive, tumbles another 18%
Moderna Inc.’s shares declined more than 17% on Friday as the sell-off continued for yet another day after the company reported worse-than-expected financial results for the third quarter of this year.
In its report published yesterday, the American vaccine maker unveiled a revenue of $5 billion, 20% less compared to market estimates. Moderna’s stock plunged 17.17% to sell for $235.14 a share at 10:22 am ET.
Get involved!
Comments